Outlook Therapeutics 株価情報 (NASDAQ: OTLK)

最新ニュース Outlook Therapeutics (NASDAQ:OTLK) 株価情報

Outlook Therapeutics

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics Inc

Deep-pocketed investors have adopted a bearish approach towards Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SMCI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 59 extraordinary options activities for Super Micro Computer. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 38% leaning bullish and 55% bearish. Among these notable options, 13 are puts, totaling $996,533, and 46 are calls, amounting to $3,064,136.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $75.0 for Super Micro Computer, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Super Micro Computer stands at 5819.84, with a total volume reaching 63,380.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Super Micro Computer, situated within the strike price corridor from $20.0 to $75.0, throughout the last 30 days.
<h3>Super Micro Computer Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739774_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/27/24</td>
<td>$10.8</td>
<td>$10.15</td>
<td>$10.45</td>
<td>$27.00</td>
<td>$522.5K</td>
<td>762</td>
<td>500</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.41</td>
<td>$2.3</td>
<td>$2.32</td>
<td>$50.00</td>
<td>$210.0K</td>
<td>27.7K</td>
<td>1.9K</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$14.8</td>
<td>$14.55</td>
<td>$14.6</td>
<td>$40.00</td>
<td>$200.7K</td>
<td>1.7K</td>
<td>293</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.35</td>
<td>$2.3</td>
<td>$2.3</td>
<td>$50.00</td>
<td>$199.4K</td>
<td>27.7K</td>
<td>2.9K</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$14.7</td>
<td>$14.55</td>
<td>$14.55</td>
<td>$40.00</td>
<td>$134.9K</td>
<td>1.7K</td>
<td>171</td>
</tr>
</tbody>
</table>

<h3>About Super Micro Computer</h3>
Super Micro Computer Inc provides high-performance server technology services to cloud computing, data center, Big Data, high-performance computing, and "Internet of Things" embedded markets. Its solutions include server, storage, blade and workstations to full racks, networking devices, and server management software. The firm follows a modular architectural approach, which provides flexibility to deliver customized solutions. The Company operates in one operating segment that develops and provides high-performance server solutions based upon an innovative, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.
<h3>Where Is Super Micro Computer Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 56,929,073, with SMCI's price up by 2.08%, positioned at $35.15.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 13 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Super Micro Computer, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

SMCI

A Closer Look at Super Micro Computer's Options Market Dynamics

Deep-pocketed investors have adopted a bullish approach towards Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HIMS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 39 extraordinary options activities for Hims &amp; Hers Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 33% bearish. Among these notable options, 7 are puts, totaling $267,231, and 32 are calls, amounting to $2,381,538.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $40.0 for Hims &amp; Hers Health over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale activity within a strike price range from $15.0 to $40.0 in the last 30 days. 
<h3>Hims &amp; Hers Health 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739768_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$4.2</td>
<td>$4.1</td>
<td>$4.2</td>
<td>$30.00</td>
<td>$322.6K</td>
<td>3.8K</td>
<td>1.3K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$21.5</td>
<td>$20.3</td>
<td>$21.02</td>
<td>$15.00</td>
<td>$210.2K</td>
<td>393</td>
<td>204</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/06/24</td>
<td>$7.9</td>
<td>$7.7</td>
<td>$7.8</td>
<td>$22.50</td>
<td>$154.4K</td>
<td>492</td>
<td>401</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$32.00</td>
<td>$120.0K</td>
<td>2.5K</td>
<td>2.3K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$12.0</td>
<td>$11.7</td>
<td>$11.7</td>
<td>$25.00</td>
<td>$93.6K</td>
<td>3.3K</td>
<td>96</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
After a thorough review of the options trading surrounding Hims &amp; Hers Health, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Hims &amp; Hers Health</h3>
<ul>
<li>With a trading volume of 21,362,792, the price of HIMS is down by -0.54%, reaching $30.52.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>Expert Opinions on Hims &amp; Hers Health</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $24.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler downgraded its action to Neutral with a price target of $21. 
&#x2A; An analyst from Canaccord Genuity persists with their Buy rating on Hims &amp; Hers Health, maintaining a target price of $28. 
&#x2A; An analyst from TD Cowen has revised its rating downward to Buy, adjusting the price target to $28. 
&#x2A; An analyst from B of A Securities has revised its rating downward to Underperform, adjusting the price target to $18. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Hims &amp; Hers Health, which currently sits at a price target of $28. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims &amp; Hers Health with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Datadog.
Looking at options history for Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 54% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $900,889 and 6, calls, for a total amount of $822,240.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $195.0 for Datadog over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Datadog's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Datadog's whale trades within a strike price range from $115.0 to $195.0 in the last 30 days. 
<h3>Datadog Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739762_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DDOG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.55</td>
<td>$4.25</td>
<td>$4.33</td>
<td>$135.00</td>
<td>$519.6K</td>
<td>1.1K</td>
<td>1.2K</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.58</td>
<td>$2.24</td>
<td>$2.48</td>
<td>$160.00</td>
<td>$434.0K</td>
<td>2.9K</td>
<td>1.9K</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$7.0</td>
<td>$6.9</td>
<td>$6.9</td>
<td>$165.00</td>
<td>$207.0K</td>
<td>463</td>
<td>303</td>
</tr>
<tr>
<td>DDOG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$14.8</td>
<td>$14.65</td>
<td>$14.8</td>
<td>$155.00</td>
<td>$148.0K</td>
<td>81</td>
<td>100</td>
</tr>
<tr>
<td>DDOG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$14.0</td>
<td>$13.7</td>
<td>$13.7</td>
<td>$155.00</td>
<td>$116.4K</td>
<td>152</td>
<td>0</td>
</tr>
</tbody>
</table>

<h3>About Datadog</h3>
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.
After a thorough review of the options trading surrounding Datadog, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Datadog Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,784,292, with DDOG's price down by -0.24%, positioned at $154.02.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 76 days.</li>
</ul>
<h3>What Analysts Are Saying About Datadog</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $153.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Datadog, which currently sits at a price target of $157. 
&#x2A; An analyst from Scotiabank persists with their Sector Outperform rating on Datadog, maintaining a target price of $133. 
&#x2A; An analyst from TD Cowen downgraded its action to Buy with a price target of $165. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Datadog, which currently sits at a price target of $165. 
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Datadog, maintaining a target price of $148. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Datadog, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

DDOG

Looking At Datadog's Recent Unusual Options Activity

WIIM

NTNX

Nutanix shares are trading lower following Q1 financial results. The stock initially gained but has since reversed.

Sets Record Straight on Mischaracterization of AIM's Historical Share Price
Reminds AIM Shareholders of Activist Group's Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
Urges Shareholders to Safeguard AIM by Voting "FOR" ALL Four of the Board's Incumbent Candidates and Discarding Any Proxy Materials Received from the Activist Group
AIM ImmunoTech Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIM#NYSE">AIM</a>) ("AIM" or the "Company") today issued the following statement refuting the false and misleading claims recently made by a group of activist investors (collectively, the "Activist Group") relating to their multi-year attempt to take over AIM's Board of Directors (the "Board") at the upcoming 2024 Annual Meeting of Stockholders (the "Annual Meeting"), presently scheduled for December 17, 2024.
Since 2016, the Board and management team have worked to overcome multiple obstacles, refocus the Company's clinical development programs to high-value indications, improve its financial condition and lay the foundation for long-term shareholder value creation. To be clear, the Board and management are unhappy with the Company's stock price performance – but they are doing everything possible to continue the significant momentum with Ampligen – which is ultimately what will create long-term value for all shareholders.

News

Management

AIM ImmunoTech Refutes Activist Group's False And Misleading Claims; Urges Shareholders To Safeguard Aim By Voting "For" All Of The Board's Incumbent Candidates And Discarding Any Proxy Materials Received From The Activist Group

Having $1 million in the bank <a href="https://www.benzinga.com/24/11/42173927/how-rich-are-you-find-out-whether-you-rank-as-upper-middle-or-lower-class-based-on-income-and-other-factors">would make someone feel rich</a>. But in America today, nearly 70% of millionaires don't consider themselves wealthy, according to a 2024 Northwestern Mutual research study. That's right – 70%. What's behind this surprising self-perception? It turns out that it's not just about how much money they have but how they measure up in a world where the definition of "wealthy" keeps shifting.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Wealth Isn't What It Used to Be
A million dollars once felt like an untouchable milestone. Many millionaires say it's not enough to feel "rich." According to a Charles Schwab survey, Americans believe it takes $2.5 million in net worth to be considered wealthy – up from $2.2 million just two years ago in 2022. Even financial security feels out of reach for some, with the average person saying they'd need $778,000 just to feel comfortable.
Why? It's partly because wealth is relative. The value of a dollar depends on where you live and how much your neighbors earn. A seven-figure net worth may sound impressive, but in cities like <a href="https://www.benzinga.com/personal-finance/24/11/41953504/can-you-guess-which-state-has-the-highest-concentration-of-millionaire-households-heres-a-hint-its-not-new-york-or-california">San Francisco or New York</a>, owning a home, covering child care and keeping up with rising living costs can be a struggle.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
This comes at a time when Americans are wealthier than ever. In fact, there are more millionaires in the U.S. today than at any point in history. Recent data shows that household net worth across the country has surpassed $160 trillion, while the number of individuals with a liquid net worth of $1 million or more has hit a record high.&nbsp;
The Trap of Lifestyle Creep
Another factor is what financial planners call "lifestyle creep." As people make more money, their expenses tend to rise just as quickly. Millionaires aren't immune to this. Earning more often leads to spending more – on bigger homes, luxury cars and private schools. Eric Roberge, a certified financial planner, explains to Investopedia that it still feels tight whether they're making $50,000 or $500,000. "The expenses are still there. They're just bigger," he added.
This pattern makes it tough to feel wealthy, even when the income looks substantial. The margin between what they earn and spend can feel precariously thin for many.
Trending: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a>
Retirement Worries Are Universal
It's easy to assume that millionaires would feel more secure about retirement and in some ways, they do. The survey found nearly 87% of high-net-worth individuals feel prepared for retirement, compared to just 54% of the general population. But that doesn't mean they're worry-free. Concerns about taxes, health care costs and outliving their savings keep even the wealthiest up at night.
The tax burden, in particular, is a major issue. With most retirement accounts taxed upon withdrawal, even millionaires worry about how much of their savings will be left after Uncle Sam takes his cut.
Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Financial Discipline Over Flash
Interestingly, despite not feeling rich, millionaires tend to be more disciplined with their money than average people. About 78% of millionaires identify as "disciplined financial planners," compared to 45% of the general population. Many work closely with financial advisors, with 69% enlisting professional help versus only 33% of non-millionaires.
This focus on planning, rather than feeling wealthy highlights a key mindset among millionaires. They prioritize protecting and growing their assets over indulging in the trappings of wealth.
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
The Self-Made Majority
Here's another surprising twist: most millionaires are self-made. The study found that nearly 80% of millionaires earned wealth through hard work and smart financial decisions. Only 11% inherited their money and just 6% came into it through a windfall like winning the lottery.
This self-made status contributes to their cautious mindset. They've built their fortunes, often through years of saving and investing and they're acutely aware of how easily it could all disappear.
Rethinking ‘Rich'
Next time you hear someone say, "A million dollars isn't what it used to be," know they're probably right. In today's world, <a href="https://www.benzinga.com/personal-finance/24/10/41499567/do-you-know-what-you-need-to-be-rich-heres-what-people-think-you-need-vs-what-data-says-actually">being rich</a> is about much more than the numbers in your bank account – it's about how those numbers stack up to the life you're trying to live.
If you want to feel more secure about your financial future – no matter your income – <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">consulting a financial advisor</a> can be a smart move to build a plan that works for you.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
</ul>

Personal Finance

70% Of Millionaires Don't Think They're Rich – Even Though People Are Wealthier Than Ever, They Don't Feel It

Whales with a lot of money to spend have taken a noticeably bearish stance on Booking Holdings.
Looking at options history for Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) we detected 34 trades.
If we consider the specifics of each trade, it is accurate to state that 32% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $298,400 and 29, calls, for a total amount of $3,095,714.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3800.0 and $7500.0 for Booking Holdings, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Booking Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Booking Holdings's significant trades, within a strike price range of $3800.0 to $7500.0, over the past month.
<h3>Booking Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739064_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$565.5</td>
<td>$555.3</td>
<td>$565.5</td>
<td>$4900.00</td>
<td>$791.7K</td>
<td align="right">34</td>
<td align="right">29</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$570.5</td>
<td>$559.0</td>
<td>$559.0</td>
<td>$4900.00</td>
<td>$279.5K</td>
<td align="right">34</td>
<td align="right">5</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$557.9</td>
<td>$547.9</td>
<td>$557.9</td>
<td>$4900.00</td>
<td>$278.9K</td>
<td align="right">34</td>
<td align="right">14</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$567.9</td>
<td>$547.9</td>
<td>$558.0</td>
<td>$4900.00</td>
<td>$223.2K</td>
<td align="right">34</td>
<td align="right">9</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1466.0</td>
<td>$1456.1</td>
<td>$1466.0</td>
<td>$3800.00</td>
<td>$146.6K</td>
<td align="right">52</td>
<td align="right">38</td>
</tr>
</tbody>
</table>

<h3>About Booking Holdings</h3>
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
<h3>Where Is Booking Holdings Standing Right Now?</h3>
<ul>
<li>With a volume of 82,428, the price of BKNG is down -0.01% at $5214.28. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 85 days.</li>
</ul>
<h3>What The Experts Say On Booking Holdings</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $5221.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Booking Holdings with a target price of $4700. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Booking Holdings with a target price of $5250. 
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Outperform rating for Booking Holdings, targeting a price of $5155. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Booking Holdings, which currently sits at a price target of $5400. 
&#x2A; Maintaining their stance, an analyst from Tigress Financial continues to hold a Strong Buy rating for Booking Holdings, targeting a price of $5600. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Booking Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

BKNG

A Closer Look at Booking Holdings's Options Market Dynamics

Deep-pocketed investors have adopted a bullish approach towards Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PLTR usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 27 extraordinary options activities for Palantir Technologies. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 6 are puts, totaling $394,321, and 21 are calls, amounting to $1,134,569.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $75.0 for Palantir Technologies over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Palantir Technologies's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Palantir Technologies's significant trades, within a strike price range of $25.0 to $75.0, over the past month.
<h3>Palantir Technologies 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739059_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$12.3</td>
<td>$12.15</td>
<td>$12.3</td>
<td>$75.00</td>
<td>$269.3K</td>
<td>4.3K</td>
<td align="right">18</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$10.15</td>
<td>$10.05</td>
<td>$10.11</td>
<td>$70.00</td>
<td>$101.1K</td>
<td>1.1K</td>
<td align="right">176</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.77</td>
<td>$2.77</td>
<td>$2.77</td>
<td>$60.00</td>
<td>$76.1K</td>
<td>12.3K</td>
<td align="right">919</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.65</td>
<td>$7.6</td>
<td>$7.65</td>
<td>$60.00</td>
<td>$74.9K</td>
<td>19.4K</td>
<td align="right">313</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$16.5</td>
<td>$16.3</td>
<td>$16.3</td>
<td>$75.00</td>
<td>$73.3K</td>
<td>249</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Palantir Technologies</h3>
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. The Denver-based company was founded in 2003 and went public in 2020.
Having examined the options trading patterns of Palantir Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Palantir Technologies Standing Right Now?</h3>
<ul>
<li>With a volume of 43,863,013, the price of PLTR is up 0.11% at $65.81. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 68 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Palantir Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

PLTR

Check Out What Whales Are Doing With PLTR

Whales with a lot of money to spend have taken a noticeably bullish stance on Roblox.
Looking at options history for Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 75% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $53,900 and 6, calls, for a total amount of $312,515.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $55.0 for Roblox over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Roblox's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Roblox's substantial trades, within a strike price spectrum from $40.0 to $55.0 over the preceding 30 days.
<h3>Roblox Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732739053_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.95</td>
<td>$2.86</td>
<td>$2.95</td>
<td>$55.00</td>
<td>$118.0K</td>
<td>1.2K</td>
<td align="right">470</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$12.0</td>
<td>$11.8</td>
<td>$12.0</td>
<td>$40.00</td>
<td>$60.0K</td>
<td>420</td>
<td align="right">50</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.13</td>
<td>$1.08</td>
<td>$1.13</td>
<td>$55.00</td>
<td>$45.1K</td>
<td>18.4K</td>
<td align="right">689</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.2</td>
<td>$3.1</td>
<td>$3.2</td>
<td>$50.00</td>
<td>$32.0K</td>
<td>5.1K</td>
<td align="right">181</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.15</td>
<td>$1.12</td>
<td>$1.15</td>
<td>$50.00</td>
<td>$28.7K</td>
<td>585</td>
<td align="right">298</td>
</tr>
</tbody>
</table>

<h3>About Roblox</h3>
Roblox operates an online video game platform with 80 million daily active users that lets young gamers create, develop, and monetize games (or "experiences") for other players. The firm offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning $3.5 billion in bookings in 2023 through in-game purchases and advertising while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers than creating new games or franchises.
Having examined the options trading patterns of Roblox, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Roblox</h3>
<ul>
<li>With a volume of 4,074,456, the price of RBLX is down -0.12% at $49.0. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 70 days.</li>
</ul>
<h3>Professional Analyst Ratings for Roblox</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $60.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Roblox, targeting a price of $65. 
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Roblox, maintaining a target price of $50. 
&#x2A; In a cautious move, an analyst from Raymond James downgraded its rating to Strong Buy, setting a price target of $60. 
&#x2A; An analyst from Morgan Stanley upgraded its action to Overweight with a price target of $65. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Roblox with a target price of $60. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Roblox, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

RBLX

What the Options Market Tells Us About Roblox

Economist and trader Alex Krüger on Wednesday shared his prediction of potential stages for the remainder of the bull market, anticipating Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to lead the way for<a href="https://www.benzinga.com/money/bitcoin-price-prediction"> a broader market rally.</a>
What Happened: In a <a href="https://x.com/krugermacro/status/1860543189939290227">post</a> on X, shared seven potential stages, based on patterns observed in 2021 and 2024. 
Bitcoin rallies in Stage 1, sparking a broader market uptrend, leading meme coins to join in stage 2.
In stage 3, altcoins join the rally, followed by an initial correction or &#8220;flush,&#8221; which the analyst foresees at Bitcoin prices of around $110,000 to $120,000. 
Stage 4 sees the &#8220;mania&#8221; continue into Christmas or the inauguration. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42214467/bitcoins-2020-thanksgiving-massacre-to-repeat-or-is-the-holiday-a-turning-point-for-new-highs">Bitcoin&#8217;s 2020 &#8216;Thanksgiving Massacre&#8217; To Repeat Or Is The Holiday A &#8216;Turning Point For New Highs&#8217;?</a>
A secondary, less intense rally in stage 5 would extend into February or early March before a substantial market correction in stage 6, potentially triggered by tax-related profit-taking in March. 
Krüger highlights March as a critical month due to tax season pressures in the U.S., which historically prompts profit-taking.
He advises traders to front-run this trend by taking profits in February to mitigate potential losses during the correction phase. 
Stage 7 would conclude with a smaller, &#8220;less manic&#8221; recovery.
The trader noted the self-reinforcing nature of crypto market patterns, where herd behavior amplifies both rallies and corrections. 
Traders&#8217; historical pain from past losses often drives their decision-making, creating predictable cycles, such as the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41124852/bitcoin-halving-cycle-signals-potential-2024-rally-canaccord-analysts-predict">Bitcoin halving cycle.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42211674/bitcoin-at-93000-crash-or-pause-bullish-outlook-for-2025-says-10x-research">Bitcoin At $93,000—Crash Or Pause? &#8216;Bullish Outlook For 2025,&#8217; Says 10x Research</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin, Meme Coins To Go Through 7 Stages Of The Bull Run Between Now And March, Trader Says

DOCU

GTLB

LDTC

ORCL

PANW

ZENA

Shares of software companies are trading lower possibly amid overall market weakness. Multiple software stocks fell after Q3 financial results.

In the current session, the stock is trading at $18.24, after a 0.55% spike. Over the past month, Huntington Bancshares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) stock increased by 14.71%, and in the past year, by 60.35%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1732737613_0.png" alt="Past Year Chart" />

<h3>A Look at Huntington Bancshares P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 19.3 in the Banks industry, Huntington Bancshares Inc. has a lower P/E ratio of 17.61. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1732737613_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

HBAN

Price Over Earnings Overview: Huntington Bancshares

Dick&#8217;s Sporting Goods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) shares are trading higher Wednesday following several analyst updates. Here&#8217;s <a href="https://www.benzinga.com/quote/DKS/news">what you need to know.</a>
What To Know: Analysts notes are rolling in after Dick's Sporting Goods reported third-quarter financial results on Tuesday. The company reported adjusted earnings per share of $2.75 for the third quarter, surpassing the analyst consensus of $2.68. Revenue for the quarter climbed 0.5% year-over-year to $3.06 billion, beating expectations of $3.03 billion, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Dick&#8217;s also raised its full-year 2024 earnings outlook to a new range of $13.65 to $13.95 per share, up from a range of $13.55 to $13.90 per share. Current estimates are calling for full-year earnings of $13.88 per share. Net sales are now projected at $13.2 billion to $13.3 billion, compared to the prior range of $13.1 billion to $13.2 billion.
Multiple analyst firms weighed in on the company&#8217;s quarterly results following the print, which appears to be adding to the momentum in the name this week.
<ul>
<li>UBS upgraded the stock to Buy and increased its price target to $260.</li>
<li>Loop Capital maintained a Hold rating and raised its price target from $220 to $225.</li>
<li>Truist Securities reiterated a Buy rating and slightly raised its price target from $256 to $258.</li>
<li>JPMorgan maintained a Neutral rating and increased its price target from $215 from $230.</li>
</ul>
In a note to clients, JPMorgan analyst Christopher Horvers highlighted Dick&#8217;s solid execution and strategic investments, including elevated store concepts like House of Sport and Field House. However, the analyst flagged risks from elevated inventory levels, which rose 13.5% year-over-year, primarily in footwear and fleece.
Horvers also pointed to Dick's broader strategy of differentiating itself through premium merchandise and omnichannel advancements. While the company continues to expand its market share, JPMorgan expects more modest margin improvements as expenses rise, including rent and SG&amp;A costs.
Telsey analyst Joseph Feldman also noted Dick's strong market position, premium product offerings and momentum from brand partnerships with names like Hoka, On and Nike.
&#8220;These brands, together with its private label portfolio (~13% of sales), have allowed the company to bridge the gap between performance and lifestyle. Dick&#8217;s also continues to elevate and modernize its omnichannel capabilities and roll out new and exciting store concepts, like House of Sport and Field House, making it the go-to destination for all things athletic,&#8221; Feldman said.
What Else: 
<ul>
<li>Store Expansion: Dick&#8217;s opened three House of Sport stores in the third quarter, bringing the total to 19, with plans for 15 more in 2025. The company also launched five new Field House stores and is phasing out its Warehouse Clearance concept in favor of Going, Going, Gone! locations.</li>
<li>GameChanger Growth: The company's SaaS-based GameChanger platform saw 21% growth in unique users year-over-year, contributing to a projected $100 million in 2024 sales.</li>
</ul>
DKS Price Action: Dick&#8217;s Sporting goods shares were up by 0.96% at $214.25 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="528" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27142108/DKS-1024x528.png" alt="" class="wp-image-668111" style="width:429px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27142108/DKS-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27142108/DKS-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27142108/DKS-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27142108/DKS.png 1467w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42222155/animal-crossing-meets-minecraft-in-ubisofts-upcoming-game-report">Animal Crossing Meets Minecraft In Ubisoft&#8217;s Upcoming Game: Report</a></li>
</ul>
Photo via Wikimedia Commons.

Earnings

Price Target

Movers

What's Going On With Dick's Sporting Goods Stock Wednesday?

One year after placing a record-shattering $52 billion order, Emirates Airlines voiced frustration with Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) over delays in <a href="https://www.benzinga.com/topic/aviation">aircraft deliveries</a>.
"We're a frustrated entity because we need airplanes, and we need them now," Emirates President Sir Tim Clark <a href="https://www.bnnbloomberg.ca/business/2024/11/27/emirates-frustrated-with-boeing-as-777x-delays-slow-growth/">told </a>BNN Bloomberg, extending his criticism to Airbus. He blamed both plane makers for being late and providing aircraft that didn't meet his specifications.
Boeing did not immediately respond to Benzinga&#8217;s request for comment.
Clark, who announced the deal at the 2023 Dubai Air Show, expressed uncertainty about when the first 205 Boeing 777X aircraft will finally enter service, as this flagship model is currently five years behind schedule.
Boeing's operational challenges have increased over the years, drawing significant attention after a door plug blew out on an Alaska Airlines 737 MAX flight in January.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42219612/usmexico-trade-tensions-escalate-as-mexican-peso-hits-august-2022-lows-why-is-auto-industry-most-at-risk">US–Mexico Trade Tensions Escalate As Mexican Peso Hits August 2022 Lows: Why Is Auto Industry Most At Risk?</a>
Eventually, the company appointed Kelly Ortberg as CEO in August, following his tenure as the leader of Collins Aerospace. Since taking the helm, Ortberg has focused on resolving production bottlenecks, dedicating substantial time to Seattle's manufacturing facilities.
However, a seven-week strike involving 33,000 workers halted most jet production, reducing September deliveries to just 27 737 MAX aircraft, far below the 38 allowed by regulators.
Although management has reached a strike-ending deal, the union failed to reach one of its main goals—the reinstatement of a traditional pension plan that was frozen a year ago. Per HR Brew's <a href="https://www.hr-brew.com/stories/2024/11/01/boeing-and-union-leadership-reach-a-deal-to-end-the-strike-but-will-the-lack-of-a-traditional-pension-kill-it">report</a>, analysts estimated such a deal could cost Boeing over $1.6 billion annually—a sum that the company with negative shareholder equity and over $57 billion in debt cannot afford.
In fact, Boeing still needs to undergo a significant overhaul. To manage financial strain and improve operational efficiency, it will <a href="https://www.benzinga.com/news/global/24/11/42052735/boeing-to-lay-off-over-2500-workers-in-the-us-amid-global-workforce-reduction">cut its global workforce by 10%</a>, totaling 17,000 jobs, including 2,500 in the U.S.
Despite the setbacks, Clark remains cautiously optimistic about Boeing's turnaround under Ortberg&#8217;s leadership, though he stressed the need for visible improvement soon. The delays have forced Emirates to invest $4 billion to upgrade its current fleet of A380s and older 777 jets, bridging the gap until new aircraft arrive.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/24/11/42217317/tesla-has-best-ev-under-50k-rivian-ceo-says-in-praise-of-rival-its-a-great-brand">Tesla Has Best EV Under $50K, Rivian CEO Says In Praise Of Rival: &#8216;It&#8217;s A Great Brand&#8217;</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Travel

Boeing Faces Heat From 'Frustrated' Emirates Over $52 Billion Aircraft Delays

Investors with a lot of money to spend have taken a bearish stance on Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Goldman Sachs Gr.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 46%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $284,252, and 9 are calls, for a total amount of $518,366.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $635.0 for Goldman Sachs Gr over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Goldman Sachs Gr stands at 358.08, with a total volume reaching 376.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Goldman Sachs Gr, situated within the strike price corridor from $300.0 to $635.0, throughout the last 30 days.
<h3>Goldman Sachs Gr Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732736761_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$20.75</td>
<td>$20.35</td>
<td>$20.41</td>
<td>$580.00</td>
<td>$122.6K</td>
<td align="right">142</td>
<td align="right">60</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$91.95</td>
<td>$90.85</td>
<td>$90.85</td>
<td>$520.00</td>
<td>$109.0K</td>
<td align="right">884</td>
<td align="right">20</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$274.2</td>
<td>$270.0</td>
<td>$270.0</td>
<td>$340.00</td>
<td>$108.0K</td>
<td align="right">33</td>
<td align="right">7</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.95</td>
<td>$6.6</td>
<td>$6.95</td>
<td>$520.00</td>
<td>$82.9K</td>
<td align="right">257</td>
<td align="right">120</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/13/24</td>
<td>$59.75</td>
<td>$57.8</td>
<td>$58.79</td>
<td>$550.00</td>
<td>$58.7K</td>
<td align="right">12</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Gr</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
After a thorough review of the options trading surrounding Goldman Sachs Gr, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Goldman Sachs Gr</h3>
<ul>
<li>Trading volume stands at 843,660, with GS's price down by -0.19%, positioned at $604.33.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 49 days.</li>
</ul>
<h3>Professional Analyst Ratings for Goldman Sachs Gr</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $633.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Goldman Sachs Gr, which currently sits at a price target of $585. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Goldman Sachs Gr, which currently sits at a price target of $661. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Goldman Sachs Gr with a target price of $680. 
&#x2A; In a cautious move, an analyst from HSBC downgraded its rating to Hold, setting a price target of $608. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Goldman Sachs Gr with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Decoding Goldman Sachs Gr's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bullish stance on Carnival.
Looking at options history for Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $169,158 and 13, calls, for a total amount of $754,586.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $28.0 for Carnival during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Carnival's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Carnival's whale trades within a strike price range from $20.0 to $28.0 in the last 30 days. 
<h3>Carnival Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732736755_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.93</td>
<td>$1.92</td>
<td>$1.92</td>
<td>$25.00</td>
<td>$192.3K</td>
<td>34.2K</td>
<td>1.4K</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.4</td>
<td>$1.39</td>
<td>$1.4</td>
<td>$26.00</td>
<td>$65.0K</td>
<td>2.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.42</td>
<td>$1.39</td>
<td>$1.42</td>
<td>$26.00</td>
<td>$63.0K</td>
<td>2.9K</td>
<td>3.2K</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$6.9</td>
<td>$6.8</td>
<td>$6.85</td>
<td>$22.00</td>
<td>$58.9K</td>
<td>5.1K</td>
<td>414</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.41</td>
<td>$1.36</td>
<td>$1.4</td>
<td>$26.00</td>
<td>$52.3K</td>
<td>2.9K</td>
<td>2.8K</td>
</tr>
</tbody>
</table>

<h3>About Carnival</h3>
Carnival is the largest global cruise company, with 92 ships in service at the end of fiscal 2023. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&amp;O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&amp;O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 13 million guests in 2019, prior to covid-19, a level it reached again in 2023.
Having examined the options trading patterns of Carnival, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Carnival's Current Market Status</h3>
<ul>
<li>With a volume of 6,122,744, the price of CCL is down -0.16% at $25.3. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 22 days.</li>
</ul>
<h3>Expert Opinions on Carnival</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $27.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Bernstein downgraded its rating to Market Perform, setting a price target of $26. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Carnival, which currently sits at a price target of $28. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carnival with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Carnival's Options Frenzy: What You Need to Know

Deep-pocketed investors have adopted a bearish approach towards ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NOW usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for ServiceNow. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 6% leaning bullish and 31% bearish. Among these notable options, 4 are puts, totaling $293,800, and 12 are calls, amounting to $482,760.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $700.0 to $1560.0 for ServiceNow over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for ServiceNow options trades today is 68.27 with a total volume of 273.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for ServiceNow's big money trades within a strike price range of $700.0 to $1560.0 over the last 30 days.
<h3>ServiceNow Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732736750_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$8.6</td>
<td>$6.4</td>
<td>$7.4</td>
<td>$1022.50</td>
<td>$148.0K</td>
<td align="right">1</td>
<td align="right">200</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$351.4</td>
<td>$339.7</td>
<td>$346.32</td>
<td>$710.00</td>
<td>$69.2K</td>
<td align="right">83</td>
<td align="right">2</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$347.2</td>
<td>$335.0</td>
<td>$341.9</td>
<td>$710.00</td>
<td>$68.3K</td>
<td align="right">83</td>
<td align="right">4</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$43.0</td>
<td>$41.9</td>
<td>$43.0</td>
<td>$1000.00</td>
<td>$64.5K</td>
<td align="right">50</td>
<td align="right">16</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$70.3</td>
<td>$67.2</td>
<td>$68.54</td>
<td>$1060.00</td>
<td>$54.8K</td>
<td align="right">88</td>
<td align="right">9</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
After a thorough review of the options trading surrounding ServiceNow, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>ServiceNow's Current Market Status</h3>
<ul>
<li>Trading volume stands at 503,701, with NOW's price down by -2.64%, positioned at $1041.87.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 56 days.</li>
</ul>
<h3>Professional Analyst Ratings for ServiceNow</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $1123.3333333333333.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Needham has decided to maintain their Buy rating on ServiceNow, which currently sits at a price target of $1150. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on ServiceNow with a target price of $1150. 
&#x2A; An analyst from Mizuho persists with their Outperform rating on ServiceNow, maintaining a target price of $1070. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for ServiceNow with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In NOW Options

As December approaches, Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) has revealed the exciting lineup of games coming to its <a href="https://www.benzinga.com/topic/playstation-plus">PS Plus subscription service</a>.
PlayStation is also celebrating its 30th anniversary with a series of special events for players, as detailed in a<a href="https://blog.playstation.com/2024/11/27/playstation-plus-monthly-games-for-december-it-takes-two-aliens-dark-descent-temtem/?sf275598532=1"> blog post.</a>
The December offerings will be available from Dec. 3 to Jan. 6, and they include a mix of genre-defining titles, beloved classics, and fresh experiences for both new and long-time fans of the PlayStation ecosystem.
See Also: <a href="https://www.benzinga.com/24/11/42219464/shuhei-yoshida-to-leave-playstation-after-30-years-id-like-to-stay-in-the-industry-xboxs-phil-spencer-reacts">Shuhei Yoshida To Leave PlayStation After 30 Years: &#8216;I&#8217;d Like To Stay In The Industry&#8217;; Xbox&#8217;s Phil Spencer Reacts</a>
<h3 class="wp-block-heading">December PS Plus Games: A Diverse Lineup</h3>
PS Plus subscribers across all tiers—Essential, Extra, and Premium—can expect three standout titles to download in December:
<ul>
<li>It Takes Two (PS4, PS5): This award-winning cooperative adventure from Hazelight Studios has captivated players with its heartfelt story and innovative gameplay mechanics. Players will be tasked with navigating the emotional journey of two dolls brought to life, as they work together to overcome obstacles and save their relationship.</li>
<li>Aliens: Dark Descent (PS4, PS5): Set in the iconic Alien universe, this real-time tactical action game invites players to control a squad of Colonial Marines battling to survive the deadly xenomorphs. With a gripping narrative and intense combat, it&#8217;s a must-play for fans of the franchise.</li>
<li>TemTem (PS5): A Pokémon-inspired MMO adventure, TemTem offers an expansive world where players can capture, train, and battle unique creatures known as TemTem. The game continues to evolve, and its arrival on PS Plus gives players an easy entry point into this growing online community.</li>
</ul>
<h3 class="wp-block-heading">Warhammer 40K Space Marine 2 Trial For Premium Members</h3>
In addition to the December games, PS Plus Premium members will get access to a new game trial for Warhammer 40K Space Marine 2, starting Dec. 3. The trial will give players the chance to experience the high-octane, third-person shooter set in the Warhammer universe before deciding if they want to purchase the full game.
<h3 class="wp-block-heading">PS2 Classics Make A Comeback</h3>
For Premium subscribers, the classics catalogue will also expand with three iconic PS2 platformers:
<ul>
<li>Sly 2: Band of Thieves</li>
<li>Sly 3: Honor Among Thieves</li>
<li>Jak and Daxter: The Precursor Legacy</li>
</ul>
<h3 class="wp-block-heading">Free Online Multiplayer And Esports Tournament</h3>
Sony is also offering a free online multiplayer weekend from Dec. 6-8 for both PS4 and PS5 users, meaning players won&#8217;t need a PS Plus subscription to enjoy online gaming during this period.
Furthermore, PlayStation will host an esports tournament during the same weekend, featuring popular titles like EA Sports FC 25, NBA 2K25, Tekken 8, Mortal Kombat 1, Madden NFL 25, College Football 25, UFC 5, MLB The Show 24, and Guilty Gear Strive. 
<h3 class="wp-block-heading">Exclusive Offers And Sweepstakes</h3>
In addition to the game releases, Sony is celebrating PlayStation's 30th anniversary with several special promotions:
<ul>
<li>30 months of PS Plus Premium: A sweepstakes will be held from Dec. 10-23, where 30 winners will each receive 30 months of PS Plus Premium.</li>
<li>30% off films on Sony Pictures Core: From Dec. 3-9, PlayStation users will be able to enjoy significant discounts on films available through Sony's streaming platform.</li>
<li>Film credit on Sony Pictures Core: From Dec. 10 to Jan. 10, any purchase of a 12-month PS Plus membership will include a film credit for Sony Pictures Core.</li>
</ul>
<h3 class="wp-block-heading">Don&#8217;t Miss Out On November&#8217;s Games</h3>
As December&#8217;s games arrive, PlayStation subscribers should make sure to grab November's titles before they disappear. This month, players can still download:
<ul>
<li>Hot Wheels Unleashed 2: Turbocharged</li>
<li>Ghostwire: Tokyo</li>
<li>Death Note Killer Within</li>
</ul>
These titles will no longer be available after Dec. 3, so act fast if you haven't already added them to your library.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/24/11/42222627/alibaba-vs-pdd-a-grim-showdown-in-chinese-e-commerce-stocks">Alibaba Vs. PDD: A Grim Showdown In Chinese E-Commerce Stocks</a></li>
</ul>
Image courtesy: PlayStation.

Gaming

General

Sony Group Corporation American Depositary Shares

SONY

PS Plus December Lineup: New Games, Exclusive Trials And 30th Anniversary Surprises

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.
The Dow traded down 0.28% to 44,734.33 while the NASDAQ fell 0.66% to 19,048.75. The S&amp;P 500 also fell, dropping, 0.37% to 5,999.25.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42188912/jim-cramer-linde-is-a-terrific-company-sees-another-stock-up-75-as-not-done">Jim Cramer: Linde Is A &#8216;Terrific&#8217; Company, Sees Another Stock Up 75% As &#8216;Not Done&#8217;</a>
Leading and Lagging Sectors Real estate shares jumped by 0.9% on Tuesday.
In trading on Tuesday, information technology shares fell by 1.4%.
Top Headline
The US core PCE price index increased by 0.3% month-over-month in October, the same pace as in the previous month, in-line with market estimates.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Urban Outfitters, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares shot up 19% to $47.68 following third-quarter earnings. Citigroup upgraded the stock to Buy following the report.</li>
<li>Shares of Iris Energy Limited &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) got a boost, surging 30% to $12.39 on the heels of the company's first-quarter financial results. Multiple analysts raised price targets following the print.</li>
<li>Unusual Machines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#NYSE">UMAC</a>) shares were also up, gaining 74% to $9.30 after the company announced that Donald Trump Jr. has joined its advisory board.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares dropped 38% to $23.02 after the company cut its first-quarter revenue forecast.</li>
<li>Shares of Outlook Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>) were down 63% to $1.7999 after the company announced it plans to resubmit the biologics license application for ONS-5010 after reporting preliminary topline results of its Norse eight clinical trial.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) was down, falling 13% to $34.21 after the company reported fourth-quarter financial results and issued first-quarter adjusted EPS guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.7% to $68.28 while gold traded up 0.7% at $2,638.70.
Silver traded down 0.9% to $30.120 on Wednesday, while copper rose 0.7% to $4.1460.
Euro zone
European shares closed mostly lower today. The eurozone's STOXX 600 slipped 0.19%, Germany's DAX fell 0.18% and France's CAC 40 dipped 0.72%. Spain's IBEX 35 Index fell 0.33%, while London's FTSE 100 rose 0.20%.
The GfK Consumer Climate Indicator for Germany declined to a reading of -23.3 points heading into December, recording the lowest level since May.
Asia Pacific Markets
Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 falling 0.80%, Hong Kong's Hang Seng Index gaining 2.32%, China's Shanghai Composite Index climbing 1.53% and India's BSE Sensex gaining 0.29%.
Economics
<ul>
<li>The U.S. economy grew by an annualized rate of 2.8% in the third quarter, the same as in the flash reading, versus 3% in the previous quarter.</li>
<li>U.S. initial jobless claims came in unchanged at 213,000 for the week ending Nov. 23, compared to market estimates of 216,000.</li>
<li>The U.S. goods trade deficit shrank to $99.1 billion in October versus a revised gap of $108.7 billion in the previous month.</li>
<li>U.S. wholesale inventories increased by 0.2% month-over-month to $905 billion in October, compared to a 0.2% decline in the prior month.</li>
<li>The Chicago PMI fell to 40.2 in November compared to 41.6 in September.</li>
<li>U.S. crude oil inventories declined by 1.844 million barrels in the week ended Nov. 22, compared to market estimates of a 1.1 million fall.</li>
<li>U.S. personal income increased by 0.6% month-over-month to $24.96 trillion in October, while personal spending rose by 0.4% to an annualized rate of $20.1 trillion.</li>
<li>The US core PCE price index increased by 0.3% month-over-month in October, the same pace as in the previous month, in-line with market estimates.</li>
<li>U.S. pending home sales rose 2% month-over-month in October compared to a revised 7.5% gain in September.</li>
<li>The total number of active U.S. oil rigs fell by two to 477 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42210452/top-3-consumer-stocks-that-are-set-to-fly-in-q4">Top 3 Consumer Stocks That Are Set To Fly In Q4</a></li>
</ul>

Eurozone

Commodities

Trading Ideas

IREN

OTLK

UMAC

URBN

Nasdaq Down Over 100 Points; HP Shares Plunge

Thanksgiving, a time for gratitude and familial gatherings, often brings its own set of stresses and strains. Back in 2015, <a href="http://benzinga.com/cannabis">cannabis</a> was harder to access due to more restrictive laws. That year, Benzinga editor <a href="https://www.benzinga.com/author/maureen-meehan">Maureen Meehan</a> wrote an <a href="https://hightimes.com/health/science/5-scientific-benefits-to-smoking-pot-on-thanksgiving">article</a> for High Times magazine spotlighting how cannabis could take the edge off holiday chaos.
Nearly a decade later, with cannabis now mainstream in much of the U.S., we're revisiting and expanding her list to explore how this versatile plant can scientifically improve your Thanksgiving experience.
Here are 10 science-backed reasons why cannabis might just be the ultimate holiday companion:
<h3 class="wp-block-heading">1. Stimulates Appetite And Enhances Taste</h3>
Cannabis is known to trigger the munchies. A 2014 <a href="https://www.smithsonianmag.com/science-nature/scientific-explanation-how-marijuana-causes-munchies-180949660/?utm_source=chatgpt.com">study</a> found that THC, the primary psychoactive component, enhances the sense of smell and taste, leading to increased appetite—perfect for enjoying the Thanksgiving feast.
<h3 class="wp-block-heading">2. Improves Social Bonding</h3>
The &#8220;love hormone&#8221; oxytocin is associated with social bonding. A <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4653148/">study</a> from the University of California Irvine discovered that cannabinoids interact with the same brain areas as oxytocin, potentially improving interpersonal connections during family gatherings.
<h3 class="wp-block-heading">3. Aids Digestive Health</h3>
Cannabis has protective effects on the stomach lining. A 2013 <a href="https://www.sciencedirect.com/science/article/abs/pii/S0163782711000026?via%3Dihub">study</a> published in the Journal of Physiology and Pharmacology indicated that cannabinoids could help manage digestive disorders, reducing discomfort after a heavy meal.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">4. Reduces Anxiety</h3>
Feeling stressed about family interactions? <a href="https://www.sciencedaily.com/releases/2014/03/140306142803.htm">Research</a> from Vanderbilt University suggests that boosting the body&#8217;s natural cannabinoid levels with cannabis can alleviate anxiety, helping you stay calm during tense moments.
<h3 class="wp-block-heading">5. Safer Alternative To Alcohol</h3>
Cannabis is considered <a href="https://www.benzinga.com/markets/cannabis/23/11/35943879/cannabis-vs-alcohol-which-is-preferable-for-better-sleep-among-those-suffering-from-anxiety">safer than alcohol</a>, especially <a href="https://www.benzinga.com/markets/cannabis/24/02/36969871/is-weed-worse-than-alcohol-for-driving-new-study-challenges-common-dui-assumptions">when it comes to driving</a> and avoiding hangovers. Opting for cannabis over that extra glass of wine might make for a clearer morning after.
Read Also: <a href="https://www.benzinga.com/government/regulations/24/11/42173811/hemp-and-thanksgiving-from-the-mayflower-to-independence-the-crop-that-helped-build-a-nation">Hemp And Thanksgiving: From The Mayflower To Independence, The Crop That Helped Build A Nation</a>
<h3 class="wp-block-heading">6. Provides Pain Relief</h3>
A large-scale Canadian study found that <a href="https://www.benzinga.com/markets/cannabis/24/01/36578723/huge-study-reveals-cannabis-provides-similar-pain-relief-benefits-as-opioids-without-negative-co">cannabis offers similar pain relief benefits as opioids</a> but without the negative consequences like respiratory depression. This could be beneficial for managing chronic pain during the holidays.
<h3 class="wp-block-heading">7. Boosts Mental Capacity</h3>
Research from the University of Bonn suggests that low doses of THC may reverse brain aging and <a href="https://www.benzinga.com/markets/cannabis/24/08/40536603/can-thc-turn-back-the-clock-cannabis-reverses-brain-aging-boosts-mental-capacity-new-study-sugge">enhance cognitive functions</a>. This could keep conversations lively and engaging at the dinner table.
<h3 class="wp-block-heading">8. Reduces Inflammation</h3>
A study co-published by Gb Sciences (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBLX#OTC">GBLX</a>) demonstrated that certain cannabinoids and terpenes in cannabis <a href="https://www.benzinga.com/markets/cannabis/22/11/29510362/cannabis-terpenes-reduce-inflammation-says-gb-sciences-study">have anti-inflammatory properties</a>. This might help alleviate minor aches or discomfort from long hours of preparation and socializing.
<h3 class="wp-block-heading">9. Improves Sleep Quality</h3>
Struggling with sleep after the festivities? Recent research from Washington State University found that over 80% of cannabis users replaced over-the-counter or prescription sleep aids with cannabis. Strains high in THC, CBD and myrcene <a href="https://www.benzinga.com/markets/cannabis/23/11/35952698/cannabis-users-ditch-conventional-sleep-aids-for-natural-remedy-new-study-finds">can improve sleep duration</a>, helping you wake up refreshed.
<h3 class="wp-block-heading">10. Elevates Mood Without Affecting Creativity</h3>
While cannabis may not boost creativity, a study from the University of Washington found that <a href="https://www.benzinga.com/markets/cannabis/23/04/31948043/cannabis-does-not-make-you-more-creative-concludes-study-more-cheerful-yes">it can improve mood</a>. A happier mindset can contribute to a more enjoyable holiday experience for everyone involved.
As always, <a href="https://www.benzinga.com/news/legal/24/11/42177984/joe-biden-how-about-pardoning-non-violent-cannabis-prisoners-along-with-those-thanksgiving-turkeys">consume responsibly</a> and be mindful of local laws and regulations. Enjoy a happier, healthier and more connected celebration.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41054426/top-10-cannabis-harm-reduction-tips-for-safer-use-and-better-experiences">Top 10 Cannabis Harm Reduction Tips For Safer Use And Better Experiences</a></li>
</ul>
Image generated with AI tools.

Cannabis

Health Care

GBLX

Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday

Outlook Therapeutics, Inc. (OTLK) Q3 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Outlook Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/otlk-stock-quote/">OTLK</a>) just reported results for the third quarter of 2024.<ul><li>Outlook Therapeutics reported earnings per share of -83 cents. This was above the analyst estimate for EPS of -$1.01.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/otlk-stock-earnings-outlook-therapeutics-for-q3-of-2024/">OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024

Analyst Tim Chiang from Capital One Financial assigned a Buy rating on Outlook Therapeutics (OTLK – Research Report) and keeping the price target a...

Outlook Therapeutics Poised for Growth: Strong Buy Recommendation Amidst Positive Clinical and Financial Developments

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outlook Therapeutics (OTLK – Research Report), Arr...

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), Arrowhead Pharmaceuticals (ARWR) and Syndax Pharmaceuticals (SNDX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outlook Therapeutics (OTLK – Research Report), 60 ...

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)

Outlook Therapeutics: Poised To Jump With Wet AMD Treatment If It Can Overcome FDA Hurdles

In a report released today, Tim Chiang from Capital One Financial assigned a Buy rating on Outlook Therapeutics (OTLK – Research Report), with a pr...

Buy Rating Affirmed for Outlook Therapeutics Amid Strong Market Potential and Upcoming Milestones for ONS-5010/Lytenava

BTIG analyst Julian Harrison reiterated a Buy rating on Outlook Therapeutics (OTLK – Research Report) today and set a price target of $50.00. Julia...

Outlook Therapeutics: Poised to Capitalize on Market Opportunities with LYTENAVA Amidst Industry Shifts

Outlook Therapeutics (OTLK) announced preliminary topline results of Norse Eight, the second of two adequate and well controlled clinical trials ev...

Outlook Therapeutics reports preliminary results from Norse Eight trials

Outlook plunges as lead asset fails in wet AMD study

ARWR

GRTS

SNDX

SXTP

Press Releases

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial

Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series

Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series

Legal

OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference

Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Anixa Biosciences

Avalo Therapeutics

Cabaletta Bio

Cibus

Coya Therapeutics

Cardiff Oncology

Immunic

INmune Bio

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Invizyne Technologies Inc. - Common Stock

Invizyne Technologies

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Leap Therapeutics

MediciNova

Monopar Therapeutics

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

Pyxis Oncology

Regulus Therapeutics

Repare Therapeutics

Skye Bioscience

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

BTIG

Ascendiant Capital

Chardan Capital

HC Wainwright & Co.

Guggenheim

Outlook Therapeutics shares are trading lower after the company announced it plans to resubmit the biologics license application for ONS-5010 after reporting preliminary topline results of its Norse eight clinical trial.

Comments

Outlook Therapeutics

ニュース

最新ニュース Outlook Therapeutics (NASDAQ:OTLK) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル